BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24879062)

  • 1. A comparative study of the effects of inhibitory cytokines on human natural killer cells and the mechanistic features of transforming growth factor-beta.
    Lee HM; Kim KS; Kim J
    Cell Immunol; 2014 Jul; 290(1):52-61. PubMed ID: 24879062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of c-Myb in the regulation of natural killer cell activity.
    Shin HW; Lee YJ; Kim J
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2807-2813. PubMed ID: 30103947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-2/IL-18 prevent the down-modulation of NKG2D by TGF-beta in NK cells via the c-Jun N-terminal kinase (JNK) pathway.
    Song H; Hur DY; Kim KE; Park H; Kim T; Kim CW; Bang S; Cho DH
    Cell Immunol; 2006 Jul; 242(1):39-45. PubMed ID: 17070508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique phenotype of human uterine NK cells and their regulation by endogenous TGF-beta.
    Eriksson M; Meadows SK; Wira CR; Sentman CL
    J Leukoc Biol; 2004 Sep; 76(3):667-75. PubMed ID: 15178706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic studies of transforming growth factor-beta inhibition of IL-2-dependent activation of CD3- large granular lymphocyte functions. Regulation of IL-2R beta (p75) signal transduction.
    Ortaldo JR; Mason AT; O'Shea JJ; Smyth MJ; Falk LA; Kennedy IC; Longo DL; Ruscetti FW
    J Immunol; 1991 Jun; 146(11):3791-8. PubMed ID: 1851793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAPK/AP-1-dependent regulation of PAI-1 gene expression by TGF-beta in rat mesangial cells.
    Guo B; Inoki K; Isono M; Mori H; Kanasaki K; Sugimoto T; Akiba S; Sato T; Yang B; Kikkawa R; Kashiwagi A; Haneda M; Koya D
    Kidney Int; 2005 Sep; 68(3):972-84. PubMed ID: 16105028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cell regulation of NK-cell responses involves lymphotoxin-α, IL-12, and TGF-β.
    Sarhan D; Palma M; Mao Y; Adamson L; Kiessling R; Mellstedt H; Österborg A; Lundqvist A
    Eur J Immunol; 2015 Jun; 45(6):1783-93. PubMed ID: 25773885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-beta inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes.
    Bright JJ; Sriram S
    J Immunol; 1998 Aug; 161(4):1772-7. PubMed ID: 9712043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD160-activating NK cell effector functions depend on the phosphatidylinositol 3-kinase recruitment.
    Rabot M; El Costa H; Polgar B; Marie-Cardine A; Aguerre-Girr M; Barakonyi A; Valitutti S; Bensussan A; Le Bouteiller P
    Int Immunol; 2007 Apr; 19(4):401-9. PubMed ID: 17307798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-beta does not inhibit IL-12- and IL-2-induced activation of Janus kinases and STATs.
    Sudarshan C; Galon J; Zhou Y; O'Shea JJ
    J Immunol; 1999 Mar; 162(5):2974-81. PubMed ID: 10072548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of interleukin-12- and interleukin-15-induced natural killer cell activation by interleukin-4.
    Salvucci O; Mami-Chouaib F; Moreau JL; Thèze J; Chehimi J; Chouaib S
    Eur J Immunol; 1996 Nov; 26(11):2736-41. PubMed ID: 8921963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
    Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG
    Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of cytokine production and AP-1 transcriptional activity in T cells by thalidomide-related immunomodulatory drugs.
    Schafer PH; Gandhi AK; Loveland MA; Chen RS; Man HW; Schnetkamp PP; Wolbring G; Govinda S; Corral LG; Payvandi F; Muller GW; Stirling DI
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1222-32. PubMed ID: 12649301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential utilization of Janus kinase-signal transducer activator of transcription signaling pathways in the stimulation of human natural killer cells by IL-2, IL-12, and IFN-alpha.
    Yu CR; Lin JX; Fink DW; Akira S; Bloom ET; Yamauchi A
    J Immunol; 1996 Jul; 157(1):126-37. PubMed ID: 8683106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colocalization of the IL-12 receptor and FcgammaRIIIa to natural killer cell lipid rafts leads to activation of ERK and enhanced production of interferon-gamma.
    Kondadasula SV; Roda JM; Parihar R; Yu J; Lehman A; Caligiuri MA; Tridandapani S; Burry RW; Carson WE
    Blood; 2008 Apr; 111(8):4173-83. PubMed ID: 18174382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated alpha 2-macroglobulin reverses the immunosuppressive activity in human breast cancer cell-conditioned medium by selectively neutralizing transforming growth factor-beta in the presence of interleukin-2.
    Harthun NL; Weaver AM; Brinckerhoff LH; Deacon DH; Gonias SL; Slingluff CL
    J Immunother; 1998 Mar; 21(2):85-94. PubMed ID: 9551359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway.
    Viel S; Marçais A; Guimaraes FS; Loftus R; Rabilloud J; Grau M; Degouve S; Djebali S; Sanlaville A; Charrier E; Bienvenu J; Marie JC; Caux C; Marvel J; Town L; Huntington ND; Bartholin L; Finlay D; Smyth MJ; Walzer T
    Sci Signal; 2016 Feb; 9(415):ra19. PubMed ID: 26884601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of the Janus kinase-STAT pathway and biologic function of IL-13 in primary human NK and T cells: a comparative study with IL-4.
    Yu CR; Kirken RA; Malabarba MG; Young HA; Ortaldo JR
    J Immunol; 1998 Jul; 161(1):218-27. PubMed ID: 9647227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor β-mediated suppression of antitumor T cells requires FoxP1 transcription factor expression.
    Stephen TL; Rutkowski MR; Allegrezza MJ; Perales-Puchalt A; Tesone AJ; Svoronos N; Nguyen JM; Sarmin F; Borowsky ME; Tchou J; Conejo-Garcia JR
    Immunity; 2014 Sep; 41(3):427-439. PubMed ID: 25238097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription factor AP-1 regulates TGF-beta(1)-induced expression of aldose reductase in cultured human mesangial cells.
    Jiang T; Qu JJ; Nishinaka T; Zhang N
    Nephrology (Carlton); 2008 Jun; 13(3):212-7. PubMed ID: 18315703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.